While beauty standards have begun to shift towards inclusivity and self-acceptance, living with a visible skin condition like vitiligo can still pose immense emotional and psychological challenges.
Results in vitiligo came from the TRuE-V1 and TRuE-V2 studies, which showed that around 30% of patients treated with ruxolitinib cream twice daily achieved 75% or more improvement from baseline in ...